NCT04332653 2026-03-09
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
Phase 1/2 Completed
NeoImmuneTech
Jazz Pharmaceuticals
Peking University Cancer Hospital & Institute
Hoffmann-La Roche
SN BioScience
Shandong Cancer Hospital and Institute
University Hospital, Strasbourg, France